Menu
X

Clinical trials

  1. CAPItello-281 (AstraZeneca)

Capivasertib + Abiraterone as Treatment for Patients with Metastatic Hormone-Sensitive Prostate Cancer Characterised by PTEN deficiency.

Referral letter

Please find below the contact details for the sites participating in the CAPI281 study.

  • Charlotte Maxeke Hospital, Johannesburg (WITS Clinical Research)
    • Principal Investigator: Dr Dineo Tshabalala
    • Site contact no.: 011-339-0600
  • Cape Town Oncology Trials, Cape Gate Oncology Centre, Cape Town
    • Principal Investigator: Dr Conrad Jacobs
    • Site contact no.: 021-944-3832
  • Curo Oncology, Les Marais Pretoria
    • Principal Investigator: Dr Rouchelle Marais-Nieman
    • Site contact no.: 012-335-6771
  • Netcare Milpark Hospital, Johannesburg (MERC SiReN)
    • Principal Investigator: Dr Yusuf Mayet
    • Site contact no.: 010-020-2428
  • Cancercare, Langenhoven Drive Oncology Centre, Port Elizabeth
    • Principal Investigator: Dr Jorn Malan
    • Site contact no.: 041-363-0581
  • Chris Hani Baragwanath Hospital, Johannesburg (WITS Clinical Research)
    • Principal Investigator: Dr Dineo Tshabalala
    • Site contact no.: 011-983-6501
  • University of Pretoria, Clinical Research unit (Accellacare)
    • Principal Investigator: Dr Krishanthavathie Pillay
    • Site contact no.: 012-319-2166
  • Tygerberg Hospital, Cape Town
    • Principal Investigator: Dr Henriette Burger
    • Site contact no.: 021-938-5736

Contact:  Junaid Maloko РNetcare Millpark | Tel +27 10 020 2428 | Junaid.maloko@peermedctc.com

2. Research Study – MSc Student. Health Behaviors of Cancer Survivors

Click here to access survey.

Should you have any queries please email  180189610@aston.ac.uk

Coming soon…

Coming soon…

Coming soon…

Coming soon…

Coming soon…

All Rights Reserved. Temple | Wisdom Online | Privacy Policy